共 50 条
Regenerative application of stromal vascular fraction cells enhanced fat graft maintenance: clinical assessment in face rejuvenation
被引:23
|作者:
Gentile, Pietro
[1
]
Sterodimas, Aris
[2
]
Calabrese, Claudio
[3
]
De Angelis, Barbara
[1
]
Trivisonno, Angelo
[4
]
Pizzicannella, Jacopo
[5
]
Dionisi, Laura
[6
]
De Fazio, Domenico
[7
]
Garcovich, Simone
[8
]
机构:
[1] Univ Roma Tor Vergata, Dept Surg Sci Plast & Reconstruct Surg, Sch Med, Rome, Italy
[2] Metropolitan Gen Hosp, Dept Plast & Reconstruct Surg, Athens, Greece
[3] San Rossore Clin, Breast Unit Dept, Pisa, Italy
[4] Univ Roma La Sapienza, Dept Surg Sci, Rome, Italy
[5] Ss Annunziata Hosp, ASL02 Lanciano Vasto Chieti, Chieti, Italy
[6] Dionisi Law Firm, Rome, Italy
[7] Galeazzi Hosp, Inst Plast Surg, Milan, Italy
[8] Univ Cattolica Sacro Cuore, F Policlin Gemelli IRCSS, Inst Dermatol, Rome, Italy
关键词:
Adipose-derived stromal vascular fraction cells;
SVFs;
face rejuvenation fat graft;
Fat graft;
PLATELET-RICH PLASMA;
STEM-CELLS;
ASSISTED LIPOTRANSFER;
BREAST AUGMENTATION;
SUPPORTIVE USE;
NASAL DORSUM;
ADIPOSE;
RECONSTRUCTION;
ADIPOCYTES;
THERAPIES;
D O I:
10.1080/14712598.2020.1815703
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
Objectives The aim of this study was to evaluate the safety and efficacy of the use of FG-SVFs in face rejuvenation for esthetic improvement. Methods 33 female patients affected by face's soft-tissue defects with loss of volume, study group (SG), were treated with FG-SVFs, comparing results with a control group (CG) (n = 30) treated with fat graft not enhanced (FG). Clinical evaluation, a photographic assessment, magnetic resonance imaging (MRI), and ultrasound (US) were performed. Post-operative follow-up was performed at 1, 3, 7, 12, 24, 48, weeks, and then annually. Results SG patients showed 61% maintenance of the contour restoring and of volume after 3 years compared with the CG treated with FG, who showed 31% maintenance. 60.7% (n = 20) of SG patients, presented an increase of 6.6 mm in the soft tissue volume after 36 months, which was reported in only 33,3% (n = 10) of the CG. Volumetric persistence in the SG was higher than that in the CG (p <. 0001 vs. CG). MRI and US moreover confirmed the absence of important side effects, as fat necrosis, and cytosteatonecrotic areas. Conclusions The use of FG-SVFs was safe and effective in this series of a case treated.
引用
收藏
页码:1503 / 1513
页数:11
相关论文